Sidebar
In an ideal world, the price of a vial of vaccine would be consistent across the globe. But at this ...
How can we best mitigate future pandemic waves while limiting collateral economic damage? As COVID-19 social distancing measures are relaxed ...
If there is any doubt whether COVID-19 has changed the economy, simply look at the investment allocations for healthcare. The ...
More transmissible variants and slower rollout of vaccines increase downside risk to herd immunity timeline. Issues include manufacturing and supply ...
Cell and gene therapies offer treatment, and sometimes cures, for patients with serious, often rare, and never-before-addressed diseases. And many ...
Systems thinking can help policymakers understand and influence the spread of infection and its multifaceted consequences across the community since ...
COVID-19 Projections machine learning team cites the following notes in their live analysis of herd immunity in the United States. ...
We have an opportunity to reach the peak of this current wave by the end of January if we can ...
Europe seems to have turned the corner on their most recent upswing in cases. But if past patterns hold true, ...
Cases in the United States are increasing, and increasing at an unprecedented rate - portending an increase in the number ...
The distribution of new cases in the US has shifted from the Northeast to the Southern and Western states. Pink ...
Demand for hospital resources are likely to increase by the end of January 2021 - with a distinctly sharper rate ...
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy